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CDKon of viral proteins by cellular enzymes is a feature of many virus replication
strategies. Here, we report that during infection the multifunctional human inﬂuenza A virus NS1 protein is
phosphorylated at threonine-215. Substitution of alanine for threonine at this position reduced early viral
propagation, an effect apparently unrelated to NS1 antagonizing host interferon responses or activating
phosphoinositide 3-kinase signaling. In vitro, a subset of cellular proline-directed kinases, including cyclin
dependent kinases (CDKs) and extracellular signal-regulated kinases (ERKs), potently phosphorylated NS1
protein at threonine-215. Our data suggest that CDK/ERK-mediated phosphorylation of NS1 at threonine-215
is important for efﬁcient virus replication.
© 2008 Elsevier Inc. All rights reserved.IntroductionReversible phosphorylation of serine, threonine, and tyrosine
residues is a well-documented method by which cellular kinases can
control the structure, function, and subcellular localization of protein
substrates [reviewed in Cohen, 2000]. As with numerous host-cell
processes,many viruses have evolved strategies to take advantage of this
normal regulatorymechanism, thereby enhancing their own replication.
The inﬂuenza A virus NS1 protein is a multifunctional virulence factor
that promotes virus propagation by modulating viral RNA metabolism,
host innate immune responses, and several cell signaling pathways
[reviewed inHale et al., 2008]. Earlywork indicated that during infection
NS1 is phosphorylated at two distinct residues, which are likely to be
threonines (Privalsky and Penhoet, 1978; 1981). In this study, we sought
to determine the biological signiﬁcance of NS1 protein phosphorylation,
and to identify the host-cell signaling pathways involved.
Results and discussion
NS1 protein is phosphorylated during infection
To conﬁrm that NS1 is phosphorylated, we infected a human lung
epithelial cell-line (A549) with the human inﬂuenza virus A/Udorn/l rights reserved.72 (Ud). After 12 h, cells were metabolically labelled with either
[32P]-orthophosphate or [35S]-methionine, and cell lysates were sub-
jected to immunoprecipitation using an NS1-speciﬁc antiserum. A
[32P]-orthophosphate labelled band corresponding to NS1 was clearly
detectable in immunoprecipitates from virus-infected (but not mock-
infected) cell lysates (Fig. 1a). Interestingly, analysis of immunoprecipi-
tates from [35S]-methionine labelled lysates revealed at least two distinct
polypeptide species corresponding to NS1. The major [35S]-methionine
labelled NS1 polypeptide had fastest mobility, whilst a minor species
with slower mobility was also observed (Fig. 1a). Strikingly, the
mobility of the minor [35S]-methionine labelled species corresponded
exactly with that of [32P]-orthophosphate labelled NS1 (Fig. 1a). We
conclude that only a subpopulation of the total NS1 protein
synthesised at any given time during infection is phosphorylated.
Identiﬁcation of NS1 phosphorylation sites by mass spectrometry (MS)
A permissive, non-transformed human lung ﬁbroblast cell-line
(MRC-5) was infected with the human inﬂuenza virus strains A/WSN/
33 (WSN) or Ud, and total-cell lysates were prepared after 12 h. MRC-5
cells were used as viral protein expression is easily detectable over
host-cell background, and the WSN/NS1 polypeptide (unlike Ud/NS1)
readily separates from other viral proteins (particularly M1) by SDS-
PAGE. Gel slices corresponding to NS1 were excised and subjected to
in-gel tryptic digestion and MS. Analysis of the resulting mass spectra
showed that our data covered 85% of the WSN/NS1 protein (Fig. 1b),
Fig. 1. Thr-215 of NS1 is phosphorylated during infection. (a) NS1 protein was immunoprecipitated from [35S]-methionine or [32P]-orthophosphate labelled A549 cells infected for
12 h (or mock) with rUd virus (5 PFU/cell). SDS-PAGE followed by autoradiography was used to visualize labelled polypeptides. (b) MRC-5 cells were infected with rWSN (5 PFU/cell)
for 12 h and total-cell polypeptides were separated by SDS-PAGE. Figure shows peptide coverage (bold) obtained after nanoLC-ESI MS/MS of the tryptic peptide mixture
corresponding toWSN/NS1 protein. Asterisks denote serine, threonine, and tyrosine residues not covered. (c) Doubly charged signals corresponding to the phosphorylated and non-
phosphorylatedWSN/NS1 peptide SSNENGRPPL(p)TPK. The phospho-peptidewas isolated (d) and subjected to low energy collision-induced dissociation resulting in the neutral loss
of H3PO4. (e) Phosphatase treatment results in disappearance of the phospho-peptide signal. Comparison of high energy collision-induced dissociation of the phospho-peptide (f) and
the non/de-phosphorylated peptide (g). Analysis of the fragmentation patterns determined the site of phosphorylation as Thr-215. The y ion series is labelled along with the
prominent b and a ions.
7Rapid Communicationbut only 75% of the Ud/NS1 protein (Supplementary Figure S1).
However, between the two NS1 proteins our data included all
common serines, threonines, and tyrosines except Thr-5, Ser-7, Ser-
8, and Ser-42. Using an automated MASCOT algorithm to search for
NS1 peptides containing possible phosphorylated residues, a single
phospho-peptide was identiﬁed for each NS1 protein (WSN/NS1,
205SSNENGRPPLTPK217 with a Mascot Ion Score of 60; Ud/NS1,
201FAWGSSNENGRPPLTPK217 with a Mascot Ion Score of 73) (Fig. 1c
and Supplementary Fig. S1). Phosphorylation of the WSN/NS1 peptide
was conﬁrmed by the diagnostic loss of 98 Da (i.e. loss of 49 Da from
the doubly charged ion) seen in the MS/MS spectrum at low collision
energies (Fig. 1d), and by disappearance of the doubly-charged 738.9
signal upon phosphatase treatment (Fig. 1e). Similar results were
obtained with Ud/NS1 (Supplementary Fig. S1). No equivalent
phospho-peptide was observed in tryptic digests of gel slices from
mock-infected cell-lysates (data not shown). The length difference
between the WSN and Ud NS1 phospho-peptides is a result of strain-
dependent sequence variation that leads to differential trypsin
cleavage. This supports the notion that the observed phospho-
peptides derive from the virus-speciﬁc NS1 protein, rather than the
host-cell.To determine the phosphorylated residue on these NS1-derived
peptides, the tryptic peptide mixture of WSN/NS1 was subjected to
high collision energy MS/MS. Interpretation of the fragmentation
pattern obtained (Fig. 1f) and comparison with that obtained for the
non-phosphorylated peptide (Fig. 1g) identiﬁed the site of phosphor-
ylation to be Thr-215. Similar results were obtained using the Ud/NS1
tryptic peptide mixture (data not shown). Interestingly, Thr-215 is
considered to be a marker for human NS1 proteins, as proline is
present at this position in most avian viruses (Finkelstein et al., 2007).
This observation may explain the previously reported strain-speciﬁ-
city regarding phosphorylation of NS1 proteins from human, but not
avian, inﬂuenza viruses (Petri et al., 1982), and implies potentially
important differences in how these viruses may interact with their
hosts.
Characterization of a recombinant inﬂuenza A virus expressing NS1 with
a T215A amino-acid substitution
Reverse genetics was used to engineer a recombinant Ud virus that
expressed NS1 with a T215A amino-acid substitution. The rUd/NS1-
T215A virus was clearly attenuated, as it formed small plaques in
8 Rapid CommunicationMadin–Darby canine kidney (MDCK) cells (Fig. 2a). Furthermore, the
mutant virus grew to infectious titres ∼100-fold lower than WT virus
during multi-cycle growth analysis in A549 cells (Fig. 2b). In MDCK
cells, multi-cycle replicationwas also signiﬁcantly (∼100-fold) slower,
but surprisingly the mutant virus eventually reached ﬁnal titres
similar toWT (Supplementary Fig. S2). The defect in virus propagation
in human A549 cells is not solely related to viral spread, as rUd/NS1-
T215A also grew to titres ∼10-fold lower thanWT virus during single-
cycle growth analysis (Fig. 2c). Consistent with the single-cycle
growth kinetics, the mutant virus clearly exhibited a reduction in
viral protein synthesis compared to WT at ∼6 h post-infection (Fig.
2d). It was also apparent that NS1-T215A protein was slightly delayed
in its ability to localize into discrete intra-nuclear foci during infection
(Fig. 2e and Supplementary Fig. S2). Metabolic labelling of infected
cells with [32P]-orthophosphate showed that mutant NS1 protein was
still phosphorylated (Fig. 2f), demonstrating that Thr-215 is not theFig. 2. A recombinant human inﬂuenza A virus expressing NS1 proteinwith a T215A amino-a
NS1-T215A inMDCK cells. (b) Multi-cycle growth analysis (∼0.001 PFU/cell) of rUdWTand rU
of rUd WT and rUd NS1-T215A in A549 cells. For both (b) and (c), titres represent mean valu
proﬁles of rUd WT and rUd NS1-T215A in A549 cells. Monolayers were infected at an MOI ∼
separated by SDS-PAGE and detected by autoradiography. Approximate mobilities of viral pro
or NEP. Molecular weight markers are indicated to the right. (e) Intracellular localization of
ﬁxed at the times indicated and immunostained for NS1 protein. (f) Immunoprecipitation of
rUd WT and rUd NS1-T215A carried out as described for Fig. 1a.only site of phosphorylation. Given that our MS analysis did not cover
the entire NS1 protein (Fig. 1b), it is possible that NS1 is also
phosphorylated at one of the residues not covered by our data. This
would be consistent with original studies, in which phosphorylation
was identiﬁed on at least two separate NS1 tryptic peptides (Privalsky
and Penhoet, 1981).
Although a major function of NS1 is to antagonize host innate
immune responses (Garcia-Sastre et al., 1998; Noah et al., 2003), the
ability of rUd/NS1-T215A virus to control interferon (IFN) production
by infected cells did not differ signiﬁcantly from that of WT virus
(Fig. 3a). Furthermore, rUd/NS1-T215A was attenuated in A549 cells
speciﬁcally engineered to be deﬁcient in IRF-3, a cellular transcription
factor essential for both IFN production and many other IFN-
independent antiviral effects (Hilton et al., 2006) (Fig. 3b and c).
Recently, it was reported that residue 215 of avian inﬂuenza virus NS1
proteins inﬂuences the ability of NS1 to hyperactivate humancid substitution is attenuated in tissue-culture. (a) Plaque phenotype of rUdWTand rUd
d NS1-T215A in A549 cells. (c) Single-cycle growth analysis (∼3 PFU/cell, trypsin absent)
es from three replicates. Error bars represent standard deviation. (d) Protein synthesis
3 PFU/cell. 1 h prior to harvest, cells were labelled with [35S]-methionine. Proteins were
teins are indicated to the left. The asterisk refers to a viral protein likely to be either M2
NS1 during rUd WT and rUd NS1-T215A infection (5 PFU/cell) of A549 cells. Cells were
NS1 from [35S]-methionine and [32P]-orthophosphate labelled A549 cells infected with
Fig. 3. Attenuation of rUd NS1-T215A is independent of IFN and PI3K. (a) Induction of
IFN by rUdWTand rUd NS1-T215A in A549 cells. Monolayers were infected at anMOI of
∼3 PFU/cell and supernatants were harvested at the times indicated. IFN in the
supernatants was estimated using a biological CPE-reduction assay. Bars represent
mean relative units of IFN from three replicates. Error bars represent standard
deviation. (b) IRF-3 is degraded in A549 cells expressing BVDV/NPro. Polypeptides from
naive or BVDV/NPro-expressing A549 total-cell lysates were separated by SDS-PAGE
and transferred to PVDF membrane. IRF-3 and β-actin were detected using speciﬁc
antibodies. N-terminally V5-tagged BVDV/NProwas detected using an anti-V5 antibody.
The asterisk corresponds to a non-speciﬁc cross-reacting protein that conﬁrms equal
sample loading. (c) Single-cycle growth analysis (MOI∼3 PFU/cell, trypsin absent) of
rUd WT and rUd NS1-T215A in A549-NPro cells. (d) Phosphorylation of Akt/PKB during
infection of A549 cells with rUd WT and rUd NS1-T215A. Lysates were prepared at the
times indicated post-infection (MOI∼3 PFU/cell) and subjected to SDS-PAGE followed
by transfer to PVDF membrane. NS1 and phospho-Akt/PKB (Ser-473) were detected
using speciﬁc antibodies. β-actin served as a loading control.
Fig. 4. CDKs and ERK phosphorylate Thr-215 of NS1 in vitro. (a) Screening of CMGC
family kinases for phosphorylation of full-length NS1 protein in vitro. 100 ng of each
indicated kinase was incubated with 1.5 μg GST-Ud/NS1 and analyzed for substrate
phosphorylation as described in Materials and methods. Asterisks indicate input
kinases. CDK1 and CDK2 (b), and CDK5 and ERK2 (c) phosphorylate the effector domain
of Ud/NS1, but not a mutant protein with the T215A amino-acid substitution. Kinase
assays were performed using 25 ng of the CDKs and 100 ng of ERK2 incubated with 2 μg
of substrate for 3, 10, or 30 min. Substrates were 6His-tagged Ud/NS1Δ72 and Ud/
NS1Δ72-T215A.
9Rapid Communicationphosphoinositide 3-kinase (PI3K) signaling (Heikkinen et al., 2008).
However, both WT rUd and rUd/NS1-T215A were similarly capable of
inducing Akt/PKB phosphorylation in A549 cells (Fig. 3d), suggesting
that mutation of this residue (at least for human inﬂuenza viruses)
does not cause an intrinsic defect in PI3K-activating capability. We
conclude that phosphorylation of Thr-215 must be required for
another, as yet undeﬁned, function of human NS1 proteins.
Identiﬁcation of cellular kinases that phosphorylate NS1 in vitro
Analysis of the motif surrounding Thr-215 in NS1 revealed that
proline at position +1 is highly conserved amongst most inﬂuenza A
virus strains sequenced to date. The CMGC (CDK, MAPK, GSK3, CLK)
superfamily of proline-directed kinases consists of 61 different human
kinases, which preferentially phosphorylate serine/threonine residuesthat are followed by a proline. We therefore screened a panel of
representative human CMGC kinases for their ability to phosphorylate
puriﬁed recombinant full-length GST-tagged Ud/NS1 protein in vitro.
As shown in Fig. 4a, neither the stress-activated protein kinases
(p38α/SAPK2A, p38β/SAPK2B, and p38γ/SAPK3: also known as
mitogen-activated protein kinases) nor the c-Jun N-terminal kinases
(JNK1 and JNK2)were able to phosphorylate recombinant NS1 protein.
However, it was clear that a representative cyclin-dependent kinase
(CDK5/p35) and a representative extracellular signal-regulated kinase
(ERK2) could phosphorylate Ud/NS1 (Fig. 4a). Furthermore, these two
kinases (as well as CDK1/cyclin B and CDK2/cyclin A) phosphorylated
a 6His-tagged Ud/NS1 protein that lacked the N-terminal 72 amino-
acids (RNA-binding domain) of NS1 (Fig. 4b and c). Substitution of
alanine for threonine at position 215 of NS1 effectively eliminated
phosphorylation by both the CDKs and ERK2 (Fig. 4b and c), indicating
that Thr-215 is the likely phosphorylation site in NS1 for these kinases.
Previous studies on the primary sequence speciﬁcities of proline-
directed kinases revealed that ERK1/2 preferentially phosphorylate
serine/threonine-proline motifs that also contain a proline residue at
the −2 position, as well as leucine at the −1 position (Songyang et al.,
1996). This is consistent with motifs identiﬁed within bona ﬁde ERK1/2
substrates in vivo (Songyang et al., 1996), as well as NS1 protein around
Thr-215 (Fig. 1b). Furthermore, proline at the −2 position is selected for
by CDKs, and this group of kinases also prefer lysine/arginine residues at
positions +2 and +4 (Songyang et al., 1996). Again, this is in full
agreement with the sequence surrounding Thr-215 in human inﬂuenza
A virus NS1 proteins. Given that NS1 phosphorylation was reported to
occur in the nuclei of infected cells (Privalsky and Penhoet, 1981), it is
10 Rapid Communicationworth noting that both ERKs and CDKs are predominantly active in the
nucleus (Cardoso et al., 1993; Chen et al., 1992). These observations
further substantiate the possibility that NS1 is a true biological substrate
for both ERK and CDK kinases.
We found that ERK2 has a relatively low initial rate of NS1
phosphorylation in vitro (33 U/mg). In contrast, the CDKs (particularly
CDK5) were very efﬁcient NS1 kinases (CDK1, 56 U/mg; CDK2, 138 U/
mg; CDK5, N400 U/mg). Furthermore, high-stringency motif analysis
of the Ud/NS1 amino-acid sequence using Scansite 2.0 (Obenauer et
al., 2003) strongly predicts Thr-215 phosphorylation by CDKs.
Interestingly, this algorithm also predicts that two other NS1 residues
can be phosphorylated: Ser-42, possibly by cellular protein kinase C
isoforms (PKCs); and Thr-49, possibly by Akt/PKB. In the present study
we were unable to ascertain whether Ser-42 is phosphorylated in vivo
as our MS data did not cover this residue. Although our data did cover
Thr-49, we did not detect phosphorylation at this site. However, it may
be that phosphorylation of a second site is temporally regulated. Given
that NS1 itself binds and activates PI3K (the upstream regulator of Akt/
PKB) (Hale et al., 2006), the potential Akt/PKB-mediated phosphor-
ylation of Thr-49 is intriguing.
Concluding remarks
We have identiﬁed Thr-215 as an in vivo phosphorylation site of
human inﬂuenza A virus NS1 proteins, and shown that members of
the CDK and ERK kinase families can phosphorylate this residue in
vitro. Although clearly important for efﬁcient viral replication in
tissue-culture, the precise biological function of Thr-215 phosphoryla-
tion is unknown. Indeed, future studies will have to determine
whether phosphorylation of NS1 protein in vivo is actually mediated
by a single speciﬁc kinase rather than all members of the ERK and CDK
families.
It is uncertain whether NS1 protein acts as a pseudosubstrate to
limit the activities of ERKs/CDKs, or is modiﬁed in order to carry out a
speciﬁc function. In this latter regard, it is tempting to speculate that
posttranslational modiﬁcation of NS1 is one of the factors that
determines its remarkably multifunctional nature (Hale et al., 2008).
Phosphorylation of full-length NS1 protein derived from infected cell-
lysates was reported to be wholly refractile to alkaline phosphatase
treatment (Privalsky and Penhoet, 1978; 1981). However, NS1 tryptic
phospho-peptides are sensitive to phosphatases, therefore in the
context of full-length NS1 protein it may be that phosphorylated Thr-
215 is not surface available. This could be caused by phosphorylation-
induced structural changes in this region of NS1 (which appears to be
intrinsically disordered (Hale et al., 2008a)), or masking of this site by
a viral or cellular binding partner that is speciﬁcally recruited to
phospho-NS1.
The data presented here provide additional insights into the strain-
speciﬁc interactions of NS1 with host-cell enzymes. Such studies re-
emphasize the multiple roles that cellular kinases have in inﬂuenza
virus biology, and highlight the need for future studies on other
potential NS1 posttranslational modiﬁcations.
Materials and methods
Cells, viruses, and IFN
Cells were grown as monolayers in DMEM supplemented with 10%
FBS. Methods to generate cell-lines with targeted degradation of IRF-3
have been detailed elsewhere (Hilton et al., 2006). WT and mutant
inﬂuenza viruses (Ud and WSN) were generated by reverse genetics
from cDNAs kindly provided by Prof. Robert Lamb (Northwestern
University, USA), and propagated/titrated/veriﬁed as described pre-
viously (Jackson et al., 2008). Threonine-215 in Ud/NS1 was changed
to alanine by PCR mutagenesis of the relevant NS segment cDNA
(pHH21 vector). Although NS1 and NS2/NEP are both encoded byvRNA segment 8, no amino-acid changes were introduced into NS2/
NEP. IFN in supernatants from infected monolayers was estimated
using a modiﬁed biological EMCV cytopathic effect (CPE) reduction
assay in A549 cells.
Metabolic labelling, immunoanalyses, and SDS-PAGE
Cells in 6-well plates were starved for 30 min in phosphate- or
methionine-free medium prior to metabolic labelling with [35S]-
methionine (50 μCi/well) or [32P]-orthophosphate (500 μCi/well) as
appropriate. Immunoﬂuorescence, immunoprecipitation, plaque stain-
ing, SDS-PAGE, and immunoblot analysis were carried out as before
(Hale et al., 2006). Protease and phosphatase inhibitors (Roche) were
added to all lysis buffers. Anti-V5 antibody was purchased from Serotec.
The phospho-Akt/PKB (Ser-473) antibody was from Cell Signaling
Technology. The IRF-3 antibody was from Abcam, and the β-actin
antibody was from Sigma. Generation of a rabbit anti-NS1 polyclonal
antiserum has been discussed previously (Hale et al., 2008b).
Mass spectrometry
Protein bands were digested using a ProGest Investigator in-gel
digestion robot (Genomic Solutions, Ann Arbor, MI) (Shevchenko et al.,
1996). Brieﬂy, gel cubes were destained with acetonitrile and subjected
to reduction and alkylation before digestion with trypsin at 37 °C.
Peptides were extracted with 10% formic acid and concentrated using a
SpeedVac (ThermoSavant). Peptides were then separated using an
UltiMate nanoLC (LC Packings, Amsterdam) equipped with a PepMap
C18 trap and column, using a 60 min gradient of increasing acetonitrile
concentration containing 0.1% formic acid (5–35% acetonitrile in 35min,
35–50% in a further 20 min, and 95% acetonitrile to clean the column).
The eluent was sprayed into a Q-Star Pulsar XL tandem mass spectro-
meter (Applied Biosystems, Foster City, CA) and analyzed in Information
Dependent Acquisition (IDA)mode, performing 1 s ofMS followedby 3 s
MS/MS analyses of the 2 most intense peaks seen in MS. These masses
were then excluded from analysis for the next 60 s. The experimentwas
carriedoutusinga standard rolling collisionenergy settingandagain at a
higher ﬁxed collision energy.MS/MS data for doubly- and triply-charged
precursor ionswas converted to centroiddata,without smoothing, using
the Analyst QS1.1mascot .dll data import ﬁlterwith default settings. The
MS/MS data ﬁle generated was analyzed using the Mascot 2.1 search
engine (Matrix Science, London, UK) against UniRef100 database
(January 2008), containing 5,241,852 sequences. No species restriction
was applied. The data were searched with tolerances of 0.2 Da for the
precursorand fragment ions, trypsin as thecleavage enzyme, onemissed
cleavage, carbamidomethyl modiﬁcation of cysteines as a ﬁxed
modiﬁcation, andmethionine oxidation and phosphorylation on serine,
threonine or tyrosine selected as a variable modiﬁcation.
Phosphatase treatment of tryptic peptides
Peptides were concentrated to dryness and resuspended in 50 mM
ammonium bicarbonate buffer supplemented with 2 mM MnCl2. λ
protein phosphatase (133 units, NEB, Hitchin, UK) was added to the
peptidemix and incubated overnight at 30 °C. Resulting peptides were
acidiﬁed and analyzed by nanoLC-ESI-MS/MS as described above.
Kinase assays
GST-Ud/NS1 and 6His-tagged Ud/NS1Δ72 were expressed and
puriﬁed by methods previously described (Hale et al., 2008a; Hale et
al., 2006). Recombinant active CDK1/cyclin B and CDK2/cyclin A were
from Biomol, CDK5/p35 from Invitrogen, ERK2 from Proqinase,
JNK1α1 and JNK2α2 fromUpstate, and p38/SAPKs from the University
of Dundee, UK. Kinases were used at 1 μg/mL or 4 μg/mL to
phosphorylate 60–80 μg/mL substrate for various times in 50 mM
11Rapid CommunicationTris pH 7.5, 0.1 mM EGTA, 10 mM β-mercaptoethanol, 10 mM Mg-
acetate and 0.1 mM [γ32P]-ATP at 30 °C. The reactions were stopped
with SDS, proteins separated by SDS-PAGE, and gels analyzed by
Coomassie Blue staining and autoradiography.
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